<?xml version="1.0" encoding="UTF-8"?>
<p>The largest barrier to eradication of the epidemic is lack of access to care, including diagnostic services and ART costs or prescriptions. A lack in access to care could create pockets of undiagnosed individuals while the overall trend appears to be a reduction in the size of the epidemic [
 <xref rid="pone.0200126.ref023" ref-type="bibr">23</xref>]. Various studies report between 50–96% of diagnosed individuals in the U.S. rely on public medical care to obtain their ART medications [
 <xref rid="pone.0200126.ref010" ref-type="bibr">10</xref>, 
 <xref rid="pone.0200126.ref020" ref-type="bibr">20</xref>, 
 <xref rid="pone.0200126.ref024" ref-type="bibr">24</xref>–
 <xref rid="pone.0200126.ref026" ref-type="bibr">26</xref>]. Access to care remains critical, but this has not been considered when modeling the dynamics of the epidemic [
 <xref rid="pone.0200126.ref005" ref-type="bibr">5</xref>, 
 <xref rid="pone.0200126.ref006" ref-type="bibr">6</xref>].
</p>
